Basic Information
| LncRNA/CircRNA Name | TUSC7 |
| Synonyms | TUSC7, LINC00902, LSAMP-AS1, LSAMP-AS3, LSAMPAS3, NCRNA00295 |
| Region | GRCh38_3:116709235-116723581 |
| Ensemble | ENSG00000243197 |
| Refseq | NR_015391 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | glioma tissues |
| Expression Pattern | down-regulated |
| Function Description | Previous studies13,14 indicated that FOXD2-AS1 expression was up-regulated in non-small cell lung cancer and gastric cancer. the low expression of TUSC7 was associated with poor clinicopathological characteristics of glioma, including WHO grade (p = 0.002) and KPS (p = 0.026). Then, the low TUSC7 level was correlated with shorter disease free survival (DFS) and overall survival (OS) than low level (both p = 0.05).TUSC7 may be a potential biomarker in the prognosis of glioma. |
| Pubmed ID | 28925483 |
| Year | 2017 |
| Title | Long non-coding RNA TUSC7 expression is independently predictive of outcome in glioma. |
External Links
| Links for TUSC7 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |